Enter assignee name

EPO Patents = 1

Trademarks = 24

Forward Citations = 45

Loading Chart...

27 inventors (with patents filed for the assignee):

Valery Novokhatny (3 out of 12 patents)

Thomas P Zimmerman (2 out of 14 patents)

Gary J Jesmok (2 out of 8 patents)

4. Kyle A Landskroner (2 out of 3 patents)

5. James Rebbeor (1 out of 8 patents)

6. Ulrich Betz (1 out of 11 patents)

7. Shan Jiang (1 out of 8 patents)

8. Jonathan S Strauss (1 out of 5 patents)

9. Jörg Kauling (1 out of 9 patents)

10. Hans-Jürgen Henzler (1 out of 7 patents)

11. Klaus Kaiser (1 out of 5 patents)

12. Stephan Kirchner (1 out of 2 patents)

13. Dirk Havekost (1 out of 3 patents)

14. Jeffrey A Yuziuk (1 out of 2 patents)

15. Richard Pasquinelli (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 8232369 - Device and method for precipitation of peptides (2012-07-31),

2. 7871608 - Reversibly inactivated acidified plasmin (2011-01-18),

3. 7544500 - Process for the production of a reversibly inactive acidified plasmin composition (2009-06-09),

4. 6984492 - Methods and compositions for treating herpes infections (2006-01-10),

5. 6969515 - Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin (2005-11-29),

6. 6964764 - Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin (2005-11-15),

Talecris Biotherapeutics, Inc. is a global biotherapeutic company that discovers, develops, and produces critical care treatments for people with life-threatening conditions. Their mission is to improve the lives of patients by providing innovative therapies and advancing medical research. Through their cutting-edge research and development, Talecris is dedicated to addressing unmet medical needs and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#1 in undefined, NC

#951 in North Carolina

#43,729 in US

NC, United States of America

Talecris Biotherapeutics, Inc.